Provided by Tiger Trade Technology Pte. Ltd.

Harrow Health Inc

37.27
-1.2700-3.30%
Pre-market: 37.640.3700+0.99%04:05 EDT
Volume:401.08K
Turnover:15.03M
Market Cap:1.40B
PE:-37.30
High:38.80
Open:38.50
Low:37.07
Close:38.54
52wk High:54.85
52wk Low:28.54
Shares:37.49M
Float Shares:28.93M
Volume Ratio:0.85
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9993
EPS(LYR):-0.1400
ROE:-116.07%
ROA:-0.45%
PB:91.92
PE(LYR):-266.21

Loading ...

Harrow Inc Q1 Gross Margin 61%

THOMSON REUTERS
·
May 12

Harrow Inc Q1 EPS USD -0.74

THOMSON REUTERS
·
May 12

Harrow Announces First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 12

Earning Preview: Harrow Health Inc revenue is expected to decrease by 8.03% this quarter, and institutional views are bullish

Earnings Agent
·
May 04

Harrow updates financial calendar with upcoming quarterly results release and conference call

Reuters
·
Apr 27

Harrow announces annual shareholder meeting

Reuters
·
Apr 25

Harrow Price Target Maintained With a $63.00/Share by BTIG

Dow Jones
·
Apr 17

Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW) and BioCryst (BCRX)

TIPRANKS
·
Apr 16

Harrow announces issuance of J-Code for Iopidine 1%

TIPRANKS
·
Apr 16

Harrow Inc - Iopidine 1% Assigned Permanent J-Code J2374 by CMS Effective July 1, 2026

THOMSON REUTERS
·
Apr 16

Press Release: Harrow Announces the Issuance of J-Code for IOPIDINE(R) 1%

Dow Jones
·
Apr 16

Harrow selects LogiCare3PL as U.S. distribution partner for ophthalmic products

Reuters
·
Apr 14

Harrow Price Target Cut to $65.00/Share From $74.00 by B. Riley Securities

Dow Jones
·
Apr 08

Harrow price target lowered to $65 from $74 at B. Riley

TIPRANKS
·
Apr 07

Harrow Inc : B. Riley Cuts Target Price to $65 From $74

THOMSON REUTERS
·
Apr 07

B. Riley Lowers Price Target on Harrow to $65 From $74, Keeps Buy Rating

MT Newswires Live
·
Apr 07

How Investors May Respond To Harrow (HROW) Upsizing Its 2030 Unsecured Notes For Growth Flexibility

Simply Wall St.
·
Apr 01

Harrow issues $50 million 8.625% senior notes due 2030; offering grows total 2030 notes to $300 million

Reuters
·
Mar 28

Craig-Hallum Keeps Their Buy Rating on Harrow Health (HROW)

TIPRANKS
·
Mar 25

How Investors May Respond To Harrow (HROW) Issuing US$50M In 8.625% Senior Notes For Growth

Simply Wall St.
·
Mar 25